London-based Hikma Pharmaceuticals has won approval to launch the first generic version of Vascepa, after having key Amarin patents for the heart drug invalidated.
The Australian government has ordered an investigation into the sale of counterfeit face masks in the country, following warnings from health experts and local media reports over the prevalence of fake equipment.
Taiwanese biotechnology company Personal Genomics is using California’s Pacific Biosciences for patent infringement in China.
The English High Court has finalised the terms of a trademark injunction against US pharmaceutical company Merck, Sharp and Dohme (MSD), in favour of German rival Merck KGaA.
Australian ear implants manufacturer Cochlear must pay $268 million for infringing a patent owned by a US medical research organisation.
Canada’s Department of Agriculture and Agri-Food has accused a Washington-based nursery, a fruit seller, and a fruit grower of infringing a plant patent covering the Staccato type of cherry tree.
The US has joined consensus on a World Health Organization resolution on the global handling of the COVID-19 pandemic, but disassociated itself from the IP and reproductive health services wording within the resolution.
The US government has urged a Delaware federal court to throw out patent infringement claims from Gilead Sciences over HIV prevention medicines.
The World Health Organization and Costa Rica will launch a technology pooling initiative to help fight the COVID-19 pandemic.
Sanofi is facing criticism after CEO Paul Hudson said the US was likely to have priority access on any COVID-19 vaccine produced by the French pharmaceutical company.